Conley Chee bought SYRS once, on Sep 10, 2024

Conley Chee is a Person and a biotech executive who served as President and Chief Executive Officer of Syros Pharmaceuticals beginning in December 2023, following an earlier role as the company’s Chief Commercial Officer.( He later became CEO after joining Syros from a deep background in oncology commercialization, portfolio strategy, and business development.(

Before Syros, Chee held senior leadership roles at Novartis Pharmaceuticals, including Global Head of Portfolio Management, Global Pipeline Strategy and Precision Medicine, and Vice President and Global Head of the Oncology Lung Franchise; earlier, he held multiple U.S. sales and marketing roles there. He also spent five years at Pfizer in international business development and began his career in clinical pharmacy and consulting. Chee holds an M.B.A. from the Richard Ivey School of Business at the University of Western Ontario and a B.Sc. in Pharmacy from the University of Alberta; he also completed a residency in Clinical Pharmacy at the University of British Columbia.(

Written by Perplexity from public sources.